Objective: To investigate the hypoalgesic effects of transcutaneous electrical nerve stimulation (TENS) upon low back pain (LBP) in people with multiple sclerosis (MS).
Design: A randomized double-blind placebo controlled clinical pilot study.
Subjects and setting: Fifteen people with MS were recruited and randomly allocated to one of the following groups under double blind conditions (n = 5 per group): TENS 1 (4 Hz, 200 µs), TENS 2 (110 Hz, 200 µs), placebo TENS.
Interventions: Treatment was applied for 45 minutes three times a week for six weeks with a four-week follow-up.
Outcome measures: The following outcome measures were taken at weeks 1, 6, and 10: visual analogue scale (VAS) (for current LBP, right leg pain, left leg pain); Leeds Multiple Sclerosis Quality of Life Questionnaire; Roland Morris Disability Questionnaire; Short Form-36 (SF-36) Version 1; and the McGill Pain Questionnaire (MPQ). VAS for current LBP, right and left leg pain were also taken before and after treatment, and once a week during the follow-up period.
Results: Analysis showed no statistically significant effects for any of the data. However, both active treatment groups showed a trend of improvement in the majority of the outcome measures.
Conclusion: Active TENS was more effective than placebo TENS in decreasing VAS scores following each treatment although results were not statistically significant. Further work in this area is warranted and should include a larger number of participants in the form of a randomized controlled clinical trial to determine the efficacy of this modality.
Get full access to this article
View all access options for this article.
References
1.
Leary S, Thompson A. Current management of multiple sclerosis. Int J Clin Pract2000; 54: 161–169.
2.
Maloni H. Pain in multiple sclerosis: an overview of its nature and management. J Neurosci Nurs2000; 32: 139–144.
3.
Clifford D, Trotter J. Pain in multiple sclerosis. Arch Neurol1984; 41: 1270–1272.
4.
Moulin D. Pain in multiple sclerosis. Neurol Clin1989; 7: 321–331.
5.
MS Society of Great Britain and Northern Ireland. MS symptom management survey 1997. MS Society Publication, 1997.
6.
Howarth A. Pain management for multiple sclerosis patients. Prof Nurse2000; 16: 824–826.
7.
Warke K, Tang LJ, Cramp AFL, Walsh DM, Lowe AS. Two pilot surveys to determine the prevalence, location and perceived treatment efficacy of pain in the multiple sclerosis population of Northern Ireland. Irish J Med Sci2003; 172: 10-10.
8.
Portenoy RK, Yang K, Thorton D. Chronic intractable pain: an atypical presentation of multiple sclerosis. J Neurol1988; 235: 226–228.
9.
Stenager E, Knudsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. Acta Neurol Scand1991; 84: 197–200.
McEwan L. MS pain: it's real and it can be treated. Accessed August 2003 from www.msif.org/en/symptoms_treatments/ms_by_topic
12.
Rice GPA. Treatment of secondary progressive multiple sclerosis: Current recommendations and future prospects. Biodrugs1999; 12: 267–277.
13.
Thompson AJ. Multiple sclerosis: symptomatic treatment. J Neurol1996; 243: 559–565.
14.
Moulin D. Pain in central and peripheral demyelinating disorders. Neurol Clin1998; 16: 889–897.
15.
The World of Multiple Sclerosis. Pain in MS. Accessed August 2003 from www.msif.org/en/symptoms_treatments/ms_by_topic
16.
Ellis B. Short report: transcutaneous electrical nerve stimulation for pain relief: recent research findings and implications for clinical use. Phys Ther Rev1998; 3: 3–8.
17.
Cheng RSS, Pomeranz B. Electrotherapy of chronic musculoskeletal pain: comparison of electroacupuncture and acupuncture-like transcutaneous electrical nerve stimulation. Clin J Pain1987; 2: 143–149.
18.
Gersh M, Wolf S. Application of transcutaneous electrical nerve stimulation in the management of patients with pain. Phys Ther1985; 65: 314–319.
19.
Waddell G. The backpain revolution. Edinburgh: Churchill Livingstone, 1998.
20.
Low J, Reed A. Electrotherapy explained: principles and practice, third edition. Oxford: Butterworth-Heinmann, 2000: 53–140.
21.
Stratford P, Binkley J, Riddle D, Guyatt G. Sensitivity to change of the Roland-Morris Back Pain Questionnaire. Phys Ther1998; 78: 1186–1196.
22.
Hobart J, Freeman J, Lamping D, Fitzpatrick R, Thompson A. The SF-36 in multiple sclerosis: why basic assumptions must be tested. J Neurol Neursurg Psychiatry2001; 71: 363–370.
23.
Scrimshaw SV, Maher C. Responsivness of visual analogue and McGill pain scale measures. J Manipulative Physiol Ther2001; 24: 501–508.
24.
Ford HL, Gerry E, Tennant A, Whalley D, Haigh R, Johnson MH. Developing a disease-specific quality of life measure for people with multiple sclerosis. Clin Rehabil2001; 15: 247–258.
25.
Marchand S, Charest J, Li J, Chenard J-R, Lavignolle B, Laurencelle L. Is TENS purely a placebo effect? A controlled study on chronic low back pain. Pain1993; 54: 99–106.
26.
Melzack R, Vetere P, Finch L. Transcutaneous electrical nerve stimulation for low back pain. A comparison of TENS and massage for pain and range of motion. Phys Ther1983; 63: 489–493.
27.
Wynn Parry CB, Girgis F. The assessment and management of the failed back, Part II. Int Disabil Stud1987; 9: 25–28.
28.
Moore SR, Shurman J. Combined neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation for treatment of chronic back pain: a double-blind, repeated measures comparison. Arch Phys Med Rehabil1997; 78: 55–60.
29.
Hamza MA, Ghoname EA, White PF et al. Effect of the duration of electrical stimulation on the analgesic response in patients with low back pain. Anesthesiology1999; 91: 1622–1627.
30.
Moore S, Shurman J. Combined neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation for treatment of chronic back pain: A double-blind, repeated measures comparison. Arch Phys Med Rehabil1997; 78: 55–60.
